|

Mecapegfilgrastim Injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1

Top Sponsors

  • Hebei Medical University Fourth Hospital1
  • Affiliated Hospital of Nantong University1

Indications

  • Cancer2
  • Neutropenia1
  • Myelosuppression1
  • Thoracic Neoplasms1
  • Chemoradiotherapy1

Other2 trials

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Phase 2
Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.